XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $232,787 | -94.6% | 5,054 | -96.0% | 0.00% | -100.0% |
| Q3 2023 | $4,305,116 | +24.7% | 126,028 | +40.5% | 0.01% | -15.4% |
| Q2 2023 | $3,453,604 | -8.4% | 89,704 | -14.8% | 0.01% | -76.8% |
| Q1 2023 | $3,769,832 | +10.5% | 105,332 | +21.7% | 0.06% | -9.7% |
| Q4 2022 | $3,411,365 | +7.4% | 86,517 | -1.7% | 0.06% | +1.6% |
| Q3 2022 | $3,176,000 | -35.5% | 87,971 | -45.7% | 0.06% | -55.1% |
| Q2 2022 | $4,926,000 | +4.4% | 161,927 | +4.9% | 0.14% | +7.9% |
| Q1 2022 | $4,717,000 | +109.7% | 154,308 | +114.4% | 0.13% | +80.0% |
| Q4 2021 | $2,249,000 | +2126.7% | 71,984 | +841.3% | 0.07% | +48.9% |
| Q3 2018 | $101,000 | – | 7,647 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |